Project Detail
"Is the mTOR pathway relevant in the initiation/progression and/or a putative therapeutic target in melanomas?"
 
Team
 
Sponsor
Novartis Farma
 
Dates and Lifetime
From: 2006-07-01 To: 2008-06-10
 
Reference
  
Send Email
From
To
Subject